| |
Hep C |
HIV |
| Transmission |
Through contact with infected blood. |
Through contact with infected blood, semen, vaginal fluids or breast milk. |
| How most people get it in Canada |
Reusing drug-use equipment already used by someone else, particularly equipment for injection drug use. |
Unprotected sex.
Reusing drug-use equipment already used by someone else. |
| Testing |
Antibody test looks for exposure. RNA test looks for infection.
No anonymous or rapid testing available.
|
Positive antibody test shows infection.
Both rapid and anonymous testing available at certain sites. |
| Treatment duration |
Six months to a year depending on the Hep C genotype. |
Lifelong HIV treatment. |
| Treatment regimen |
Currently, peg-interferon with ribavirin. |
Highly Active Antiretroviral Therapy (HAART) which is a combination of three or more anti-HIV drugs. |
| Response to treatment |
HCV can be completely cleared from the body if treatment is successful. 20% of people will spontaneously clear the virus and not need treatment. |
Levels of HIV can be reduced to undetectable levels but not cleared from the body. |
| How long virus survives outside the body |
HCV can survive four days (possibly up to two weeks) outside the body. |
HIV dies within minutes in open air outside the body. |
| Possibility of re-infection |
There is no immunity to HCV. Re-infection can occur even if virus was cleared before (spontaneously or through treatment). People can be infected with more than one genotype. |
Re-infection can occur sometimes with a resistant strain of HIV that does not respond to treatment. |
| Vaccine |
No vaccine currently available for HCV. |
No vaccine currently available for HIV. |
| Window period(for recommended testing) |
Three to six months after exposure to virus. |
Three to six months after exposure. |
| Part of body targeted |
HCV replicates and multiplies in the liver leading to liver damage. |
HIV targets immune cells (CD4+ cells) for replication causing weakening of the immune system. |
| Prevalence (estimates) |
Canada: 250,000 infections
Worldwide: 170 million |
Canada: 58,000 infections
Worldwide: 33 million |